CEO
SCHOTT Pharma AG & Co. KGaA
Equibles does not estimate personal net worth.
Andreas Reiße is recorded as CEO at SCHOTT Pharma AG & Co. KGaA. Andreas Reiße has spoken on 1 earnings call across 1 company, most recently for SCHOTT Pharma AG & Co. KGaA on February 11, 2026. SCHOTT Pharma AG & Co. KGaA is classified in the Medical Instruments & Supplies industry within the Healthcare sector.
“Warm welcome to everyone joining us for today's call. So I'm pleased to present an overview of our strategy and recent business developments. So we had a good start to the financial year 2026.”
SCHOTT Pharma AG & Co. KGaA
CEO
Transcript header (unverified)
SCHOTT Pharma AG & Co. KGaA
Medical Instruments & Supplies · Healthcare
CEO
Quarterly statement (Q1 2026)
SCHOTT Pharma AG & Co. KGaA
